Increasing evidence indicates that glucocorti coids (GCs), produced in response to physical/emotional stressors, can exacerbate brain damage resulting from ce rebral ischemia and severe seizure activity. However, much of the supporting evidence has come from studies employing nonphysiological paradigms in which adrena lectomized rats were compared with those exposed to constant GC concentrations in the upper physiological range. Cerebral ischemia and seizures can induce consid erable GC secretion. We now present data from experi ments using metyrapone (an II-J)-hydroxylase inhibitor of GC production), which demonstrate that the GC stress response worsens subsequent brain damage induced by ischemia and seizures in rats. Three different paradigms of brain injury were employed: middle cerebral artery occlusion (MCAO) model of focal cerebral ischemia; four-vessel occlusion (4VO) model of transient global forebrain ischemia; and kainic acid (KA)-induced (sei zure-mediated) excitotoxic damage to hippocampal CA3 and CAl neurons. Metyrapone (200 mg/kg body wt) was administered systemically in a single i.p. bolus 30 min prior to each insult. In the MCAO model, metyra-Considerable evidence suggests that glucocorti eoids (GCs), the adrenal steroids released during stress, play an important role in neurodegenerative processes. While some data indicate that chronic Address correspondence and reprint requests to Dr. M. P. Mattson at 211 Sanders-Brown Building, University of Ken tucky, Lexington , KY 40536-0230, U.S .A. Abbreviations used: ANOV A, analysis of variance; CCA, common carotid artery ; CORT , corticosterone; 4VO, four-vessel occlusion; GC, glucocorticoid ; KA, kainic acid ; MCA, middle cer ebral artery ; MCAO, middle cerebral artery occlusion; TTC , triphenyltetrazolium chloride.
Summary: Increasing evidence indicates that glucocorti coids (GCs), produced in response to physical/emotional stressors, can exacerbate brain damage resulting from ce rebral ischemia and severe seizure activity. However, much of the supporting evidence has come from studies employing nonphysiological paradigms in which adrena lectomized rats were compared with those exposed to constant GC concentrations in the upper physiological range. Cerebral ischemia and seizures can induce consid erable GC secretion. We now present data from experi ments using metyrapone (an II-J)-hydroxylase inhibitor of GC production), which demonstrate that the GC stress response worsens subsequent brain damage induced by ischemia and seizures in rats. Three different paradigms of brain injury were employed: middle cerebral artery occlusion (MCAO) model of focal cerebral ischemia; four-vessel occlusion (4VO) model of transient global forebrain ischemia; and kainic acid (KA)-induced (sei zure-mediated) excitotoxic damage to hippocampal CA3 and CAl neurons. Metyrapone (200 mg/kg body wt) was administered systemically in a single i.p. bolus 30 min prior to each insult. In the MCAO model, metyra-Considerable evidence suggests that glucocorti eoids (GCs), the adrenal steroids released during stress, play an important role in neurodegenerative processes. While some data indicate that chronic pone treatment significantly reduced infarct volume and also preserved cells within the infarct. In the 4VO model, neuronal loss in region CAl of the hippocampus was sig nificantly reduced in rats administered metyrapone. Sei zure-induced damage to hippocampal pyramidal neurons (assessed by cell counts and immunochemical analyses of cytoskeletal alterations) was significantly reduced in rats administered metyrapone. Measurement of plasma levels of corticosterone (the species-typical GC of rats) after each insult showed that metyrapone significantly sup pressed the injury-induced rise in levels of circulating cor ticosterone. These findings indicate that endogenous cor ticosterone contributes to the basal level of brain injury resulting from cerebral ischemia and excitotoxic seizure activity and suggest that drugs that suppress glucocor ticoid production may be effective in reducing brain damage in stroke and epilepsy patients. Key Words: Alzheimer's-Corticosterone-Excitotoxicity-Hippo campus-Kainic acid-Microtubule-associated pro teins-Middle cerebral artery occlusion-Transient glob al forebrain ischemia.
elevation of circulating levels of GCs alone can re sult in neuronal degeneration in the hippocampus, particularly in aged animals (Landfield et aI. , 1981; Sapolsky et aI. , 1990; Landfield, 1994) , the most striking effects of GCs are observed when the brain is subjected to excitotoxic/metabolic insults. GCs have been shown to impair the capacity of neurons to contain cascades of glutamate and calcium during neurological insults, thus exacerbating cytoskeletal pathology and neuron death (Sapolsky, 1985; Land field, 1987; Elliott et aI. , 1993; Stein-Behrens et aI. , 1994) . In vivo studies have shown excitotoxic (El liott et aI. , 1993) and ischemic (Sapolsky and Pulsinelli, 1985) injury to hippocampal neurons is greater in adrenalectomized rats exposed to con stant GC concentrations (in the upper physiological range of 15-40 f.lg/dl) than in adrenalectomized con trols . Moreover, elevated plasma GC levels in aged humans have been correlated with decreased cog nitive performance (Lupien et aI ., 1994) , an alter ation consistent with hippocampal damage. Studies of hippocampal cell cultures have shown that GCs can (a) exacerbate hypoxic and hypoglycemic neu ronal injury (Tombaugh et aI. , 1992) ; (b) reduce cel lular glucose uptake (Horner et aI., 1990) ; (c) exac erbate the toxicity of kainic acid (KA), metabolic poisons, and oxygen radical generators (Sapolsky et aI., 1988) ; (d) accelerate A TP depletion following metabolic insults Lawrence and Sapolsky, 1994) ; and (e) enhance ex citatory amino acid-induced elevation of intracellu lar calcium levels (Elliott and Sapolsky, 1992) .
The mechanism of ischemic brain injury involves a reduction in energy availability to neurons leading to a drop in ATP levels and promotion of excitotox icity (Novelli et aI. , 1988; Siesjo, 1988; Beal, 1992) . The ability of glutamate receptor antagonists to re duce neuronal injury in rodent models of focal ce rebral ischemia and transient global forebrain ische mia (Grotta et aI ., 1990; Nellgard and Wieloch, 1992) attests to the importance of excitatory amino acids in ischemic brain injury. Overactivation of ex citatory amino acid receptors induces membrane depolarization and calcium influx, which results in activation of proteases and lipases and accumula tion of reactive oxygen species, which can damage membranes and proteins and kill neurons (Siman and Noszek, 1988; Lafon-Cazal et aI., 1993; Verity et aI., 1993) . Taken together, the evidence suggests that a plausible mechanism whereby GCs increase neuronal vulnerability to excitotoxic and ischemic insults is by impairing glucose transport leading to ATP depletion and increased vulnerability to exci totoxicity (see Sapolsky, 1994 for review) .
Early studies implicating GC "endangerment" of neurons were nonphysiological in that they com pared adrenalectomized rats with those exposed to constant GC concentrations in the upper physiolog ical range. Considerable evidence indicates that neurologic insults can induce significant endoge nous GC secretion. For example, levels of circulat ing GCs were shown to be elevated in stroke pa tients (Feibel et aI., 1977; Davalos et aI., 1994; Fass bender et aI ., 1994) and in patients experiencing severe epileptic seizures (Pritchard, 199 1; Cala brese et aI., 1993) , and increased levels and dura tion of GC elevation were correlated with worse outcome. These reports suggested that endogenous J Cereb Blood Flow Metab, Vol. 16, No.4, 1996 GC secretion at the time of the insult could add to the damage. This view is supported by a study showing that metyrapone, a potent and rapid 11-13hydroxylase inhibitor of GC production, can de crease hippocampal damage due to local KA infu sion (Stein and Sapolsky, 1988) . In addition, a pre liminary report indicated that metyrapone could reduce hippocampal damage induced by transient global forebrain ischemia in the gerbil (Morse and Davis, 1989 ). In the present study, we extended preliminary findings and provide data showing that the protective effects of metyrapone are more gen eral, in that they protect against additional insults relevant to the pathogenesis of both stroke and se vere epileptic seizures (systemic KA-induced hip pocampal damage). In addition, we show that metyrapone reduces seizure-induced cytoskeletal damage to hippocampal neurons . When taken to gether with data showing that metyrapone sup pressed circulating levels of corticosterone (CORT), the species-typical GC of rats, in the early postinjury period, the findings indicate that endog enous GCs contribute to ischemia and seizure induced brain injury, and testify to the physiological and clinical relevance of GC neuroendangerment.
MATERIALS AND METHODS

Animals and experimental treatments
Male Wistar rats were used for the four-vessel occlu sion (4VO) model of transient global forebrain ischemia, and males of a spontaneously hypertensive inbred strain of Wi star rat (250-350 g, purchased from Harlan, Indi anapolis, IN, U.S.A.) were used for the middle cerebral artery occlusion (MCAO) model of focal cerebral ische mia. Male Sprague-Dawley rats (280-300 g) (Simonsen, Gilroy, CA, U.S.A. or Harlan) were used for KA lesion studies. Metyrapone (Sigma, St. Louis, MO, U.S.A.) was dissolved in sterile saline and injected either subcutane ously or intraperitoneally in a volume of 1.5 or 3 ml, respectively, (200 mg!kg body wt). For all experiments, metyrapone was administered 30 min prior to the ische mic insult or KA administration. KA (Sigma) was dis solved in sterile saline and injected either intraperitoneal ly or directly into the dorsal hippocampus. CORT (Sigma) was dissolved in peanut oil and injected subcutaneously in a volume of I ml (40 mg!kg body wt). Rats were main tained under conditions of controlled lighting (12: 12 light! dark cycle with lights on at 0700) and temperature (22°C) and allowed free access to lab chow and tap water. All experiments were performed during "lights on" hours.
MCAO model of focal cerebral ischemia
The method established by our laboratory is a modifi cation of that of Brint et at. (1988) and involves tandem occlusion of the middle cerebral artery (MCA) and ipsi lateral common carotid artery (CCA). Animals were fasted overnight prior to surgical preparation for ische mia. Rats were anesthetized with 500 mg!kg chloral hy drate for isolation of MCA and CCA. A cannula was in-serted into one femoral artery for sampling of arterial blood and measurement of systemic blood pressure. Thermistor probes were inserted into the rectum and tem poralis muscles to monitor body and brain temperature, which was maintained at 36-37°C by external warming. The left CCA was isolated through an anterior incision in the neck. A second incision was made between the lateral canthus of the left eye and the ipsilateral external audi tory canal to expose the underlying skull. Under direct visualization with a Zeiss operating microscope, the left MCA was exposed through a 2-mm burrhole drilled 2-3 mm rostral to the fusion of the zygomatic arch and the squamosal bone. The dura was opened with a sharp nee dle and an alloy wire (0. I mm diameter) was inserted beneath the MCA just superior to the inferior cortical vein. The MCA was elevated from the cortical surface and cauterized by applying electrical current to the wire. The scalp incision was closed and 4-0 silk was used to tie off the CCA. After the neck incision was sutured, the rat was returned to its cage and given free access to water and rat chow. Twenty-four h following MCAO, rats were anesthetized with chloral hydrate (500 mg/kg body wt) and perfused transcardially with saline, followed by 2% triphenyltetrazolium chloride (TTC), using our modifica tion of the technique described by Bederson et al. (1986) . The stained sample was fixed for 24 h in 10% formalin at 4°C. The brain was cut into I-mm coronal sections and infarct area was determined with a Macintosh II com puter using National Institutes of Health (NIH) Image Analysis software (version 1. 52). An optical density threshold taken from healthy gray matter in the unaf fected right hemisphere was used to create a mask that excluded infarcted (nonstaining) brain tissue. The mask was superimposed over the corresponding video image, thereby permitting exclusion of white matter tracts from the area of infarction. All measurements of infarct volume were confined to cortex and were performed by a single operator blinded to treatment status. Animals were di vided into three treatment groups: saline-treated control (n = 8), metyrapone-treated (n = 8), and metyra pone + CORT-treated (n = 7) animals.
Additional rats were prepared for each treatment group as described above for Nissl staining. Twenty-four h fol lowing MCAO, rats were anesthetized with sodium pen tobarbital and perfused transcardially with saline, fol lowed by cold 4% paraformaldehyde. The brain was re moved, blocked, and cut with a freezing microtome into 40 f.Lm sections, which stained with 0.1 % cresyl violet. Sections were visualized with an inverted Nikon Diaphot microscope under bright field for qualitative assessment of the infarcted area of the cortex.
4VO model of transient global forebrain ischemia
Transient global forebrain ischemia was accomplished with the 4VO model (Pulsinelli and Brierley, 1979) , which we adapted for modest hypotension produced by revers ible exsanguination (Geddes et aI. , 1994; Smith Swintosky et aI., 1994) . Briefly, fasted rats were anesthe tized with chloral hydrate (500 mg/kg; i. p. ), the common carotid arteries isolated with loose ligatures, and the ver tebral arteries cauterized. Preischemic and 30 min post ischemic blood glucose levels, blood gases and hemato crits were determined. Electroencephalographic (EEG) and electrocardiographic (ECG) activities were moni tored with subdermal electrodes and recorded with a Gould Graphics Recorder. Body temperature and blood pressure were monitored continuously using the same physiological standards applied to MCAO animals. Ische mia was initiated by clamping the carotid arteries with surgical clips and withdrawing arterial blood to produce a mean systemic blood pressure of 80--85 mm Hg. After 20 min of isoelectric EEG, surgical clips were removed and the shed blood infused. This method results in highly re producible delayed selective death of CAl pyramidal neu rons (Pulsinelli and Brierley, 1979; Smith-Swintosky et aI., 1994) . Seventy-two h following ischemia, rats were perfused transcardially with 4% paraformaldehyde. Brains were cut into 30 f.Lm coronal sections, which were stained with cresyl violet. Cell counts were made from high power (40 x) microscope fields of region CA 1 of the hippocampus as previously described (Smith-Swintosky et aI. , 1994) . Rats were divided into two treatment groups: control saline-treated (n = 8) and metyrapone treated (n = 9) animals.
KA administration
KA was administered either systemically or by focal injection into the dorsal hippocampus as described previ ously (Stein and Sapolsky, 1989; Elliott et aI., 1993; Stein Behrens et aI. , 1994) . For systemic administration, KA was injected intraperitoneally into unanesthetized rats in a single 1.5-ml bolus containing 15 mg KA/kg body wt. For focal KA injection into the dorsal hippocampus, rats were anesthetized with a ketamine/ropun cocktail, placed in a stereotaxic head holder, and the skull exposed along the midline. KA (0. 07 f.Lg in a volume of 1 f.LI) was injected unilaterally into dorsal hippocampus [stereotaxic coordi nates: anterior/posterior (AP) = -3.0, medial/lateral (ML) = 2. 1, dorsal/ventral (DV) = 4.0 mm from lambda]. As expected (Ben-Ari, 1985) , essentially all animals ad ministered KA (by either route) manifested seizures within the first h postinjection. In a previous study using the intrahippocampal KA administration paradigm, we recorded EEG and showed that metyrapone did not sig nificantly affect epileptiform activity (Stein and Sapolsky, 1988) . Four hours following administration of KA, rats were anesthetized with 20% urethane and perfused tran scardially with a 0.1 M phosphate-buffered saline (PBS)/ 0.5% heparin solution followed by 4% paraformaldehyde. Coronal brain sections (30 f.Lm) were cut on a freezing microtome and used for Nissl staining and immunohisto chemistry. Neuronal damage in the hippocampus induced by KA administered by these two different routes was previously characterized in considerable detail (Elliott et aI. , 1993; Stein-Behrens et aI. , 1994) . Neuronal damage was quantified as described in our previous studies (El liott et aI. , 1993; Smith-Swintosky et aI. , 1994) . Briefly, coronal brain sections were stained with cresyl violet and Nissl-positive neurons were counted in three high power 40 x microscope fields in hippocampal regions CA 1, CA3, and hilus. Counts were made in four sectionslbrain. A mean number of neurons/hippocampal region was ob tained for each animal, and determinations were made in five-to-eight rats/treatment group.
Immunohistochemistry and Western blot analysis
Coronal brain sections (30 f.Lm) were cut on a freezing microtome, and free-floating sections were immuno stained with tau or MAP2 antibodies using the bioiin avidin-peroxidase method as described previously (Elliott et aI. , 1993) . The primary antibodies included a monoclo nal antibody to MAP2 (1: 1000, vol/vol (Sigma) and a monoclonal antibody (tau-I) that recognizes an epitope on tau in a dephosphorylated state. Sections were incu bated overnight in primary antibody, followed by sequen tial incubations (with intervening PBS washes) in biotin ylated secondary antibody, avidin-peroxidase complex, and diaminobenzidine tetrahydrochloride. To control for nonspecific staining, additional sections were subjected to the immunostaining procedure without the primary an tibody.
Methods for Western blot analysis of tau and MAP2 were similar to those used in our previous studies (Matt son, 1992; 1995) . Briefly, proteins were separated by SDS-PAGE (10% acrylamide), transferred to nitrocellu lose, and then immunoreacted with primary antibodies followed by incubation with peroxidase-labeled second ary antibody (1 :4,000, vol/vol).
Quantification of plasma corticosterone levels
Radioimmunoassay was used to quantify levels of CORT in plasma samples as described previously (Stein Behrens et a\., 1994) . The procedure employed uses a highly specific CORT antibody (B3-163) (Endocrine Sci ences, Tarzana, CA, U.S.A.) and 3H-CORT tracer (Gwosdow-Cohen et a\., 1982) . This assay detects CORT levels as low as 0.95 f.lg/dl and the coefficients of variation within and between assays was < 10%. Blood samples were taken at the following times: MCAO paradigm: pre drug, 30 min postdrug (preischemia), and 60 min postis chemia; 4VO paradigm: predrug, 30 min postdrug (preis chemia), and 30 min postischemia; kainate: 30 and 90-min postkainate.
Statistical analyses
Comparisons of infarct volumes (in the MCAO ische mia paradigm) were made using analysis of variance (ANOVA) with Scheffe's post hoc test for pairwise com parisons. Comparisons of numbers of surviving CA 1 neu rons (4VO ischemia paradigm) in saline-treated control rats and metyrapone-treated rats were made using the unpaired I-test (two-tailed). Comparisons of numbers of undamaged neurons in hippocampal regions CA 1, CA3, and hilus (focal and systemic KA seizure paradigms) were made using ANOVA followed by Scheffe's post hoc test for pairwise comparisons of control and metyrapone treated groups. Comparisons of plasma CORT levels in saline-and metyrapone-treated rats were made using ANOVA and Scheffe's post hoc test for pairwise com parisons.
RESULTS
Focal ischemic injury to cortex is reduced in rats administered metyrapone
Permanent occlusion of the MeA resulted in the formation of a major infarct of the frontal cortex within 24 h (Fig. 1 ). We found that administration of metyrapone 30 min prior to the onset of ischemia significantly reduced infarct volume by 54% com pared to saline-treated control animals (p < 0. 00 1) ( Fig. 2) . Moreover, infarcts in the metyrapone treated animals contained a band of surviving cells (n = 7 of eight rats) that was never observed in Vol. 16, No.4, 1996 FIG. 1. Metyrapone reduces cortical damage induced by middle cerebral artery occlusion. Photomicrographs of TTC stained coronal brain sections from rats receiving: saline (upper panel), metyrapone (middle panel), or metyra pone + CORT (lower panel). Saline-treated animals exhibited a large cortical infarct. Infarct size was reduced in metyra pone-treated animals with a characteristic band of preserved cells appearing within the infarcted area (arrow). Metyrapone + CORT treatment resulted in modest reduction in infarct size and loss of cells in all cortical layers.
saline-injected control ischemic rats (n = 8) .. Exam ination of Nissl-stained brain sections indicated that the cells protected by metyrapone were predomi nantly located within cortical layers 4-5 (data not
Metyrapone significantly reduces infarct volume in rats subjected to middle cerebral artery occlusion. Rats were pretreated with saline, metyrapone, or metyrapone + CORT for 30 min prior to permanent occlusion of the middle cere bral artery. Rats were killed 24 h later and brains were fixed and stained with TTC to determine infarct volume. Values represent the mean and SO (n = 7-8 rats/condition). *, p < 0.05 compared to saline-treated animals; **, p < 0.001 com pared to saline-treated animals. ANOVA with Scheffe's post hoc test for pairwise comparisons.
shown). The average volume of the band of "pro tected cortex" in metyrapone-treated rats was 8 ± 3 mm3 (range = 0.0-l 7.7 mm3) ( Fig. 1 ). An addi tional group of rats was given both metyrapone and CORT prior to the onset of ischemia. If metyrapone exerted its protective effects via reduction of circu lating CORT levels, then the presence of exogenous CORT would attenuate or block the metyrapone protective effect. The mean infarct size in metyrapone + CORT rats was intermediate to in farct volumes in saline-and metyrapone-treated rats (Fig. 2 ), although the difference in values for metyrapone + CORT and metyrapone alone fell just short of statistical significance. Interestingly, none of the rats receiving metyrapone + CORT (n = 7) exhibited the band of surviving cells within the in farct that were seen in seven of eight rats receiving metyrapone alone (Fig. 1) ; this difference was highly significant (p < 0.00 1 by x2 analysis). These data indicated that the protective effect of metyra pone against MCAO-induced cortical injury was at least partially due to its ability to suppress CORT production rather than to some other action (see Discussion). Plasma levels of CORT following MCAO were significantly reduced in rats administered metyra pone, to �45% those of control rats administered saline (Fig. 3) . This reduction in CORT corre sponded with a significant decrease in infarct vol ume (Fig. 2) . Plasma CORT levels in rats treated with metyrapone + CORT were 58 ± 6.8 j.Lg/dl (n = 6), a level significantly greater than in rats admin istered metyrapone alone (p < 0.01). Based upon our previous studies (Sapolsky et aI., 1995) , basal CORT levels during the time of day at which exper iments were performed in the present study ranged from 2 to 10 j.Lg/dl, indicating that metyrapone re duces postinjury CORT levels to values somewhat higher than levels in unstressed rats .
Metyrapone reduces damage to CAl hippocampal neurons induced by transient global forebrain ischemia Twenty min of transient global ischemia resulted in the selective degeneration of CAl pyramidal neu rons by 72 h postischemia; <300 undamaged neu rons were present in CAl of ischemic rats receiving saline (Figs. 4 and 5) . Our previous studies estab lished that the normal numbers of neurons in CAl sections from nonischemic sham-operated controls ranged from 850-950 neurons (Smith-Swintosky et aI., 1994) . A 30-min treatment with metyrapone prior to the onset of the ischemic episode signifi cantly increased the number of CAl neurons sur viving 72 h following the insult (p < 0.00 1) ( Fig. 5 ).
There was a threefold increase in CAl cell survival ance. Metyrapone-treated animals displayed many healthy CAl neurons indicated by their round soma and distinct nuclei (Fig. 4) . Rats in the metyrapone treated group had a significantly lower level of plasma CORT 30 min following the ischemic insult compared to rats in the saline-treated group (Fig. 3) .
Physiological data in the ischemia paradigms Physiological variables were measured in all ani mals subjected to MCAO (Table 1) or 4VO (Table  2 ). There were no significant differences in baseline physiological variables measured prior to treatment with saline vehicle or metyrapone in either the MCAO or the 4VO paradigm. Measurements made 30 min following administration of metyrapone (im mediately prior to MCAO or 4VO ischemia) re vealed that the drug had no significant effect on any of the physiological variables. The same data were reacquired 60 min after reversal of carotid occlusion and infusion of shed blood in the 4VO animals to verify that there was no postischemic compromise of respiratory control in the medulla. We found no significant difference between saline or IDetyra pone-treated 4 VO groups after ischemia. Table 2 includes temperature data to show that neither glob al forebrain ischemia nor metyrapone treatment af- Blood pH , CO2 , O2 , and glucose were measured in arterial samples. Baseline values were obtained immediately before intraperitoneal injection of vehicle or metyrapone . Post-drug/ vehicle data were measured 30 min after injection and immediately prior to ischemia. Values represent the mean ± SD (n = 7-8 rats) .
fected rectal temperature. Temporalis muscle tem peratures were matched to rectal measurements in all animals. Table 2 also contains hematocrit data to show that the effects of reversible exsanguination during 4VO ischemia were uniform for both vehicle and metyrapone-treated rats. Postischemic blood sampling was unnecessary in MCAO animals be cause of their rapid recovery from anesthesia after CCA-MCA occlusion.
Seizure-induced damage to hippocampus is reduced in rats administered metyrapone
Adult male Sprague-Dawley rats were adminis tered convulsant doses of KA either systemically (15 mg/kg body wt) or by stereotaxic injection of 0.7 J.Lg of KA into one hippocampus. In previous stud ies, we characterized neuronal damage to hippo campal neurons in these paradigms (Elliott et aI. , 1993; Stein-Behrens et aI. , 1994) . Systemic KA ad ministration resulted in damage and death of pyra midal neurons in regions CA3 and CA 1, and hilar neurons (Stein and Sapolsky, 1989) . Focal injection of KA into the dorsal hippocampus resulted in dam age and death of CA3 and hilar neurons (Elliott et aI. , 1993) . In both cases, damage occurs relatively rapidly, within 3-12 h of administration of KA. In the present study, rats were killed 4 h following KA injection, and 30 fLm coronal brain sections were stained with cresyl violet. In control rats not receiv ing KA, there were no signs of injured cells in any regions of the hippocampus; values for neuronal numbers in regions CAl , CA3, and hilus in unin jured control rats are presented in Fig. 6A . In ani mals receiving systemic KA, the numbers of un damaged neurons in regions CAl , CA3, and hilus were significantly reduced ( Figs. 6 and 7) . Whereas normal healthy pyramidal neurons had relatively round somata with nuclei and nucleoli often visible, neurons damaged by KA were shrunken, with ir regular shapes and nuclear structures not visible (Fig. 7) . In rats administered metyrapone (200 mg! kg body wt, s.c.) 30 min prior to exposure to KA, seizure-induced neuronal damage was significantly reduced in CA 1, CA3, and hilar regions of the hip pocampus ( Figs. 6A and 7) . Damage to CA3 and hilar neurons induced by focal injection of KA into the dorsal hippocampus was also significantly re duced in rats pretreated with metyrapone ( Fig. 6B ). Quantification of blood levels of CORT 90 min fol lowing KA administration (in both systemic and fo cal KA paradigms) showed that levels were mark edly reduced in rats administered metyrapone com pared to saline-injected control rats (Fig. 3) . U sing the same seizure paradigms employed in Hematocrit and blood pH, CO2 , O2 , and glucose were measured in arterial samples. Baseline values were obtained immediately before intraperitoneal injection of vehicle or metyrapone . Post-drug/vehicle data were measured 30 min after injection and immediately prior to ischemia. Po stocclusion measurements were made 60 min after reversal of 4VO . Values represent the mean ± SD (n = 7-8 rats).
" CD
Li: the present study, we previously characterized the effects of KA on different components of the neu ronal cytoskeleton, including the microtubule associated proteins tau and MAP2, and spectrin (El liott et ai. , 1993; Stein-Behrens et ai. , 1994) . MAP2 is normally localized to dendrites throughout the hippocampus. Systemic administration of KA re sulted in a loss of MAP2 immunoreactivity that was particularly obvious in the molecular layers of CA 1 (Fig. 8) . This reduction in MAP2 immunoreactivity was largely eliminated in rats administered metyrapone prior to KA. Tau is normally localized to axons in the different molecular layers of the hippocampus. As expected, systemic KA caused a loss of tau immunoreactivity (antibody tau-I) from axons in the molecular layers (particularly obvious in the CAl region) and accumulation of tau-l im munoreactivity in region CA3 (Fig. 9, upper panel) . We previously reported that, in addition to causing a shift in tau localization (i. e. , from axons to cell bodies), excitatory amino acids can alter phosphory lation of tau, as indicated by a reduction of a higher molecular weight tau band on Western blots (Matt son, 1995) . Western blot analysis of hippocampi from KA-injected control and metyrapone-treated rats demonstrated that metyrapone largely pre vented dephosphorylation of tau, as indicated by retention of the highest molecular weight tau-l im munoreactive band, which was largely lost in KA injected control rats ( Fig. 9, lower panel) . Western blot analysis showed that levels of MAP2 following KA administration were greater in metyrapone treated rats than in rats receiving saline, indicating that metyrapone reduced KA-induced proteolysis of MAP2 ( Fig. 9, lower panel) . Taken together, these data indicate that suppression of endogenous GC production by metyrapone greatly reduces sei zure-induced injury to hippocampal neurons.
DISCUSSION
GCs have been shown to exacerbate toxicities of various neurological insults, presumably by their disruptive effects upon energetics in brain tissue (see introductory section). By inhibiting glucose up take, GCs leave neurons metabolically vulnerable and less capable of the costly task of containing damaging cascades of glutamate and calcium (re viewed in Sapolsky, 1994) . Our data add MCAO focal ischemia and systemic KA-induced seizures to the growing list of neurological insults that are exacerbated by GCs. Importantly, our data suggest that ongoing production of CORT in the postinjury period contributes to the severity of ischemia-and seizure-induced brain damage. We administered FIG. 7. Seizure-induced damage to hippocampal CA3 and CA1 neurons is reduced in rats administered metyrapone. Nissl stained coronal brain sections 4 h following systemic administration of KA from rats pretreated with saline (control; left panels) or metyrapone (right panels). Higher magnification micrographs of regions CA3 and CA1 are from the same sections shown at lower magnification in the upper micrographs. Note severe damage to CA3 and CA 1 neurons in the control rat. and reduced damage in the rat receiving metyrapone. Arrows point to damaged neurons in CA3 of the control rat and to undamaged neurons in region CA3 of the rat receiving metyrapone. metyrapone, an inhibitor of GC synthesis, to a group of rats in each injury condition. As expected, metyrapone significantly attenuated the rise in plasma CORT after either ischemia-or seizure induced injury. This suppression of plasma CORT paralleled a highly significant increase in cell sur vival such that infarct size was reduced in the MCAO focal ischemia paradigm, CAl pyramidal neurons were preserved after transient global ische mia, and hippocampal neurons were significantly protected against seizure damage induced by either local or systemic KA administration. In two seizure paradigms with different characteristic patterns of hippocampal damage (convulsions induced by sys temic KA resulting in damage to CAl , CA3, and hilar neurons; and local seizures induced by focal FIG. 8. Metyrapone reduces KA-induced alterations in MAP2 immunoreactivity in hippocampus. Coronal brain sections 4 h following systemic administration of KA from rats pretreated with saline (control; left panels) or metyrapone (right panels). Sections were immunostained with MAP2 antibody. Lower panels are high magnification micrographs of a region of CA3 from the same brain sections shown in the upper panels. KA caused a loss of MAP2 immunoreactivity from molecular layers in region CA1 (star symbol), which was largely prevented by metyrapone.
injection of KA resulting in damage to CA3 and hilar neurons only), metyrapone significantly re duced neuronal degeneration.
Levels of plasma CORT following each insult were elevated into a range suggesting a robust stress response. These levels are similar to those we have observed previously following KA microinfu sion (Stein and Sapolsky, 1988) and hypoxia ischemia (R. M.S., unpublished data) in rats. Plasma CORT levels postinjury were markedly reduced in rats administered metyrapone to levels (�1-5 jJ.g/dl) in the unstressed to moderate stress range (Sapol sky et aI. , 1985) . We found that damage to the ce rebral cortex induced by MCAO was significantly reduced in rats administered metyrapone. This is interesting in that much of the previous "GC en dangerment" literature has focused on the hippo campus. However, two previous studies, in which adrenalectomized rats were administered exoge nous GC, demonstrated increased damage to the cortex induced by ischemic insults (Sapolsky and Pulsinelli, 1985; Koide et aI. , 1986) . The present study provides several lines of evidence for a patho physiological role for endogenous CORT in focal J Cereb Blood Flow Metab, Vol. 16, No.4, 1996 ischemic damage to neocortex. First, metyrapone significantly reduced plasma levels of CORT in the postinjury period. Second, infarct volume was re duced and preserved tissue within the infarct in creased in rats administered metyrapone. Third, co administration of metyrapone and CORT resulted in plasma CORT levels higher and infarct volume greater than in rats administered metyra pone alone. More striking was the absence of pre served tissue within the infarct of rats administered metyrapone plus CORT in contrast to a highly re producible preservation of a band of tissue corre sponding to layers 4 and 5 of the cortex in rats ad ministered metyrapone alone.
In addition to exacerbating damage to neurons in different brain regions, several other data sets attest to the "generalizability" of the neuroendangering activity of endogenous CORT. The time course of neurodegeneration for each of the insults in the present study was distinct. KA caused a relatively rapid neurodegeneration of hippocampal neurons occurring within 4h (cf. Elliott et aI. , 1993) . MCAO led to a well-defined cortical infarct within 24 h (cf. Brint et aI. , 1988) . Global ischemia resulted in de-
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Metyr -280 Tau -1 layed death of CAl pyramidal neurons clearly seen by 72 h after the ischemic episode (cf. Pulsinelli and Brierley, 1979) . Our results, therefore, indicate that metyrapone has a powerful effect on neurodegener ation resulting from both rapid excitotoxicity and more protracted ischemic insults. The ability of metyrapone to reduce plasma CORT levels and pro tect against brain injury in three different injury par adigms strongly suggests that endogenous stress induced levels of CORT exacerbate ischemia-and seizure-induced brain injury. The fact that metyra pone was effective in two different strains of rat further supports a generalized neuroprotective ac tivity of this compound. We observed that postin jury levels of plasma CORT in saline-injected con trol rats were different in the three different injury paradigms: CORT levels were highest in the MCAO paradigm, intermediate in the 4VO paradigm, and lowest in the KA paradigm (Fig. 3) . These differ ences are likely due to the differences in the mag nitude of the stress response induced by the differ ent insults. However, we did not perform a com plete characterization of the time course of changes in plasma CORT levels (before and following the insult) and, therefore, did not establish the com plete profile of plasma CORT levels which may be quite different with each insult. Due to the limita tions of the animal models we employed (e. g., keep ing animals anesthetized and alive after severe neu rological insult for extended periods of time), we were only able to monitor plasma levels of CORT up to 90 min postinsult and, therefore, do not know how long CORT levels remained suppressed in the rats administered metyrapone. Metyrapone is rap idly absorbed and can significantly lower plasma CORT levels within 10 min. Its half-life is � 1-2. 5 h, such that it takes �24 h to clear >99% of the drug from the body. Therefore, it is expected that plasma CORT concentrations would be reduced for many hours following a single injection of metyrapone. Finally, differences in the strain of rat could have also contributed to the observed differences in postinjury CORT levels because the highest levels were in the Wistar strain (MCAO and 4VO) and the lowest levels were in the Sprague-Dawley strain (KA). The latter possibility is supported by previ ous evidence indicating significant differences in basal plasma CORT levels and stress response plasma CORT levels for different strains of rats (Dhabhar et aI. , 1993) . Hippocampal neuronal populations vulnerable to ischemic and excitotoxic insults express high levels of CORT receptors. Indeed, CAl and CA3 pyra midal neurons express the highest levels of type II (low affinity) GC receptors of, perhaps, any other neuronal population. Previous data indicated that it is the type II glucocorticoid receptor that mediates increased vulnerability of neurons to excitotoxicl metabolic insults (Koide et aI. , 1986; Packan and Sapolsky, 1990) . Interestingly, the neocortical re gion with the highest level of type II GC receptors (layers 4 and 5) (Van Eekelen et al. , 1987) was most markedly spared in rats administered metyrapone in the MCAO focal ischemia paradigm (Fig. 1) . These observations are consistent with the possibility that activation of GC receptors in layers 4 and 5 cortical neurons contributes to their demise following MCAO. Our data are also consistent with those of previous studies of GC endangerment that provided evidence that the mechanism involves activation of type II receptors leading to suppression of glucose uptake and increased vulnerability to excitotoxic damage (see Sapolsky, 1994 for review) . On the other hand, some of the available data are not con sistent with a classic receptor-mediated mechanism of glucocorticoid endangerment. Nongenomic ac tions of CORT should be considered in light of the fact that metyrapone protected CA3 neurons against the rapid «4 h) toxicity of KA. Such rapid actions of CORT could be mediated by membrane associated steroid receptors, such as those de scribed in brain synaptosomes (Orchinik et aI. , 1991) , or by more direct effects on membrane prop erties. Indirect actions of GCs should also be con sidered because GCs can induce release of cyto kines and fatty acids, both of which are known to induce membrane lipid peroxidation (Ahima et aI. , 1992; Herman, 1993) . Moreover, there is evidence that high concentrations of CORT or GC receptor agonists (> 30 nM) increase calcium action poten tials and voltage-sensitive calcium currents in hip pocampal neurons leading to increased levels of [Ca2+]i (Kerr et aI. , 199 1; Kerr et aI. , 1992) .
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The present studies cast light on the ways in which metyrapone is neuroprotective via its capac ity to decrease CORT secretion. In addition, metyrapone has some direct effects within the ner vous system. For example, intracerebroventricular administration of metyrapone suppresses feeding in rats (Jain et aI. , 1993) . Furthermore, metyrapone can inhibit cytochrome P450 (Fantuzzi et al., 1993 )-a mechanism that gives it some antioxidant properties (Montoliu et aI. , 1994) . Finally, metyra pone suppressed injury-induced production of tumor necrosis factor (Fantuzzi et aI. , 1993) , a cytokine that can protect hippocampal and cortical neurons against excitotoxic and metabolic insults (Cheng et J Cereb Blood Flow Metab, Vol. 16, No.4, 1996 a!. , 1994). Thus, it is important to consider that per haps the neuroprotective effects of systemic metyrapone, as documented in the present study, resulted solely from such central actions. Our data suggest that this is not the case. Co-administration of exogenous CORT with metyrapone in the MCAO paradigm resulted in plasma CORT levels equal to or greater than levels in control rats administered saline, and resulted in significantly greater cortical cell damage compared to metyrapone-treated ani mals. These data suggest that the neuroprotective actions of metyrapone were at least partially due to its effect in suppressing plasma CORT levels.
When taken together with previous findings, our data suggest that metyrapone reduces aberrant ele vation of [Ca2+]i resulting from ischemic and exci totoxic insults. The ability of GCs to worsen the elevation of [Ca2+ L induced by excitotoxicl metabolic insults, documented in previous studies (Elliott and Sapolsky, 1992; Elliott et aI. , 1993) , sug gests that the reduction of plasma CORT levels, effected by metyrapone, likely resulted in stabiliza tion of neuronal calcium homeostasis. Evidence supporting the latter possibility includes the ability of metyrapone to attenuate seizure-induced MAP2 proteolysis and alterations in tau immunoreactivity. We previously showed that administration of exog enous CORT to adrenalectomized rats (Elliott et a!. , 1993) and physiological stress in intact rats (Stein-Behrens et aI. , 1994) exacerbated KA induced MAP2 and spectrin proteolysis, and re sulted in redistribution of tau in the hippocampus. Each of these cytoskeletal alterations is believed to be mediated by calcium influx (Siman et aI. , 1984; Siman and Noszek, 1988; Mattson, 1990; Geddes et a!. , 1994; Roberts-Lewis and Siman, 1994; Mattson, 1995) . The present data suggest that the stress of a seizure itself provokes sufficient GC secretion to augment calcium accumulation and resulting cyto skeletal alterations.
Metyrapone was given 30 min prior to the onset of each of the three insults described above and significantly protected against each. Additional studies are currently in progress to determine whether administration of metyrapone after ische mic insult or administration of KA also reduces sub sequent neuronal injury and death. Such studies should reveal the potential clinical utility of metyrapone. This compound is one of several bio chemically and physiologically well-characterized inhibitors of GC synthesis and secretion. Several compounds, including metyrapone, are ul'ed clini cally in humans to test adrenal reserve in diagnostic endocrine tests. They are used therapeutically for months to inhibit GC secretion in Cushing's syn-drome (Haynes and Murad, 1985 ; Miller and Crapo, 1993; Avgerinos et aI. , 1994) and , in recent experi mental studies, have been used as a novel class of antidepressants (Rupprecht et aI. , 1991) . Sustained GC exposure resulting from prolonged stress can be neurotoxic to the primate hippocampus (Sapolsky et aI. , 1990) . Stress induces atrophy of hippocampal pyramidal neuron dendrites in rats (Watanabe et aI. , 1992) , and sustained exposure to GCs in Cushingoid humans is associated with selective hippocampal at rophy (Starkman et aI. , 1992) . If, as predicted from our data, endogenous GCs exacerbate ischemic and excitotoxic insults to the hippocampus and cortex in humans, then compounds such as metyrapone might prove protective in allaying brain damage as sociated with stroke and severe epileptic seizures .
